Corning to Highlight Cancer Research Innovations Driven by 3D Cell Culture at AACR 2018

News Releases
Life Sciences
Corning to Highlight Cancer Research Innovations Driven by 3D Cell Culture at AACR 2018
Corning to Highlight Cancer Research Innovations Driven by 3D Cell Culture at AACR 2018
Hosting tutorial on using 3D cell culture to predict glioblastoma response to chemotherapy

Corning Incorporated (NYSE: GLW) will showcase its latest solutions for cancer research, 3D cell culture, and drug discovery in exhibit 1842 at the 2018 American Association for Cancer Research Annual Meeting, April 14-18 in Chicago.

The world of 3D cell culture is expanding rapidly – from innovative organoid and spheroid development to 3D bioprinting applications and unique cancer research models for high-throughput screening. Corning is helping customers leverage 3D cell culture to create more in vivo-like studies that are accelerating cancer research and drug discovery.

Solutions featured in the Corning exhibit will include: 3D cell culture tools for cancer research, automated 3D solutions, drug screening (including ADME/Tox), sample cooling and freezing, and automated cell counting.

Corning will also host a special tutorial called “Rock the Science of 3D: From Promise to Reality” at 10 a.m., April 17 in Spotlight Theater C in the Exhibit Hall. Dr. Tessa DesRochers from KIYATEC will discuss assays that build upon the increased biological fidelity of 3D cell culture to accurately predict individual patient-specific glioblastoma response to chemotherapy. Also, Dr. Hilary Sherman, a Corning applications scientist, will explain a novel 3D glioma blood brain barrier (BBB) model for high throughput testing of tumoricidal capability.

Corning Life Sciences brings new and innovative laboratory technologies to researchers worldwide and helps customers succeed by providing innovative, high-quality products and services in the areas of polymer science, biochemistry and molecular biology, glass melting and forming, surface modification, and characterization science.

To learn more about Corning Life Sciences products, contact a customer service representative at (800) 492-1110; outside the United States, call (978) 442-2200; or visit To learn more about Corning’s 3D cell culture products, please visit:

Forward-Looking and Cautionary Statements

This press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.

Web Disclosure

In accordance with guidance provided by the SEC regarding the use of company websites and social media channels to disclose material information, Corning Incorporated (“Corning”) wishes to notify investors, media, and other interested parties that it intends to use its website ( to publish important information about the company, including information that may be deemed material to investors, or supplemental to information contained in this or other press releases. The list of websites and social media channels that the company uses may be updated on Corning’s media and website from time to time. Corning encourages investors, media, and other interested parties to review the information Corning may publish through its website and social media channels as described above, in addition to the company’s SEC filings, press releases, conference calls, and webcasts.

About Corning Incorporated

Corning ( is one of the world's leading innovators in materials science, with a more than 165-year track record of life-changing inventions. Corning applies its unparalleled expertise in glass science, ceramic science, and optical physics along with its deep manufacturing and engineering capabilities to develop category-defining products that transform industries and enhance people's lives. Corning succeeds through sustained investment in RD&E, a unique combination of material and process innovation, and deep, trust-based relationships with customers who are global leaders in their industries.

Corning's capabilities are versatile and synergistic, which allows the company to evolve to meet changing market needs, while also helping our customers capture new opportunities in dynamic industries. Today, Corning's markets include optical communications, mobile consumer electronics, display technology, automotive, and life sciences vessels. Corning's industry-leading products include damage-resistant cover glass for mobile devices; precision glass for advanced displays; optical fiber, wireless technologies, and connectivity solutions for state-of-the-art communications networks; trusted products to accelerate drug discovery and delivery; and clean-air technologies for cars and trucks.